Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 695-745-7 | CAS number: 1079221-49-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- from 15 June 2007 to 4 August 2009
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: the study was performed according to internationally recognised guidelines and GLP.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 009
- Report date:
- 2009
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- 2-({3-aminopyrazolo[1,5-a]pyridin-2-yl}oxy)ethan-1-ol hydrochloride
- EC Number:
- 695-745-7
- Cas Number:
- 1079221-49-0
- Molecular formula:
- C9 H11 N3 O2, ClH
- IUPAC Name:
- 2-({3-aminopyrazolo[1,5-a]pyridin-2-yl}oxy)ethan-1-ol hydrochloride
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Janvier, Le Genest-Saint-Isle, France
- Age at study initiation: approximately 9 weeks old
- Weight at study initiation: 21.0 ± 1.0 g
- Housing: individually in disposable crystal polystyrene cages (22 cm x 8.50 cm x 8 cm)
- Diet: free access to SsniffR/M-H pelleted diet
- Water: free access to tap water (filtered using a 0.22 micron filter)
- Acclimation period: at least 5 days before the beginning of the study
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 2°C
- Humidity: 30 to 70%
- Air changes: approximately 12 cycles/hour of filtered, non-recycled air
- Photoperiod: 12hrs dark / 12 hrs light
IN-LIFE DATES: from 20 June 2007 to 30 July 2007
Study design: in vivo (LLNA)
- Vehicle:
- propylene glycol
- Concentration:
- 1st experiment: 0, 0.1, 1.0, 10% (w/v)
2nd experiment: 0, 0.256, 0.64, 1.6, 4, 10% (w/v) - No. of animals per dose:
- 4 females
- Details on study design:
- PRELIMINARY TESTS:
- Compound solubility: the test item was not soluble in the first recommended vehicle (acetone/olive oil (4/1, v/v)), in dimethylformamide and in methylethyl ketone. The test item was soluble in propyl glycol after sonication for 10 minutes and in dimethylsulfoxide. Propylene glycol was chosen as vehicle; a solution was obtained at the maximum concentration of 10%.
- Irritation: no data
- Lymph node proliferation response: no data
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: by hand procedure (no additional information)
- Criteria used to consider a positive response: the test item was considered as a skin sensitizer when the SI for a dose group is ≥ 3 together with consideration of a dose-response relationship. Other relevant criteria such as cellularity, radioactivity levels and ear thickness were also taken into account for the interpretation of results.
TREATMENT PREPARATION AND ADMINISTRATION:
The dosage form preparation at 10% in the main test was sonicated for 10 minutes. Before preparation, the vehicle (PG) was degassed by sonication for 15 minutes, then saturated with inert gas and kept under inert atmosphere for 15 minutes.
Fresh test item dosage forms were prepared extemporaneously under inert atmosphere on the morning of each application and were kept under inert gas. Test item dosage forms were used within 30 minutes/1 hour after preparation.
The test item was tested in two independent experiments as follow:
- three or five treated groups receiving the test item at different concentrations,
- one negative control group receiving the vehicle (Propylene Glycol),
- one positive control group
On days 1, 2 and 3 of each experiment, a dose-volume of 25 μL of the control or dosage form preparations was applied to the dorsal surface of both ears. In order to avoid licking and to ensure an optimized application of the test materials, the animals were placed under light isoflurane anesthezia during the administration. No massage was performed but the tip was used to spread the preparation over the application sites. No rinsing was performed between each application.
After 2 days of resting, the proliferation of the lymph node cells in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (day 6). The obtained values were used to calculate Stimulation Indices (SI).
The irritant potential of the test item was assessed in parallel by measurement of ear thickness on days 1, 2, 3 and 6. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- The threshold positive value of 3 for the SI was exceeded in the positive control group (see tables).
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- In the first experiment, a significant lymphoproliferation was noted at the concentration of 10%. In the absence of local irritation at the concentration of 10%, the significant lymphoproliferative response observed at this concentration was attributed to contact sensitization. The EC3 value for the test item calculated on the basis of this experiment is equal to 1.9%. However, this experiment did not allow to conclude about the potential of the test item to induce contact sensitization because any dose-effect response was observed. In the second experiment, a significant lymphoproliferation was noted at the concentration of 10%. In the absence of local irritation at the concentration of 10%, the significant lymphoproliferative response observed at this concentration was attributed to contact sensitization. A dose-effect response was observed. The EC3 value for the test item calculated on the basis of this experiment is equal to 7.7%.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: See tables
Any other information on results incl. tables
Clinical examination:
No mortality was noted in the first experiment. In the second experiment, one female (No. 56) of the positive control group was found dead on day 6. No clinical signs were observed prior to its death.
In both experiments, no clinical signs were observed.
The body weight change of treated animals was similar to that of control animals.
In both experiments, no cutaneous reactions and no noteworthy increase in ear thickness were observed in the animals of the treated groups.
Table 1: results of the 1st experiment
Group |
Treatment concentration |
Viability (%) |
Cellularity index |
Dpm per group |
Dpm per node |
Stimulation index |
Increase in ear thickness (%) |
Irritation level |
EC3 value (%) |
1 |
Vehicle |
87.39 |
- |
270.95 |
33.87 |
- |
-0.98 |
- |
|
2 |
Test item 0.1% |
76.50 |
1.71 |
648.27 |
81.03 |
2.39 |
0.00 |
non irritant |
1.9 |
3 |
Test item 1% |
89.66 |
1.61 |
477.68 |
59.71 |
1.76 |
2.02 |
non irritant |
|
4 |
Test item 10% |
82.69 |
2.22 |
3836.17 |
479.52 |
14.16 |
6.06 |
non irritant |
|
5 |
HCA 25% |
93.02 |
7.42 |
9387.83 |
1173.48 |
34.65 |
- |
- |
|
Table 2: results of the 2nd experiment
Group |
Treatment concentration |
Viability (%) |
Cellularity index |
Dpm per group |
Dpm per node |
Stimulation index |
Increase in ear thickness (%) |
Irritation level |
EC3 value (%) |
1 |
Vehicle |
88.07 |
- |
698.82 |
87.35 |
- |
-2.02 |
- |
|
2 |
Test item 0.256% |
89.02 |
0.76 |
350.65 |
43.83 |
0.50 |
-3.92 |
non irritant |
7.7 |
3 |
Test item 0.64% |
72.41 |
0.66 |
321.82 |
40.23 |
0.46 |
-5.77 |
non irritant |
|
4 |
Test item 1.6% |
74.56 |
0.89 |
696.70 |
87.09 |
1.00 |
-3.96 |
non irritant |
|
5 |
Test item 4% |
92.86 |
1.63 |
1294.85 |
161.86 |
1.85 |
0.00 |
non irritant |
|
6 |
Test item 10% |
91.24 |
1.84 |
2588.09 |
323.51 |
3.70 |
0.00 |
non irritant |
|
7 |
HCA 25% |
93.82 |
4.64 |
4120.10 |
686.68 |
7.86 |
- |
- |
|
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the experimental conditions of the study, the test item induced contact sensitization in the murine Local Lymph Node Assay.
A significant lymphoproliferation was noted at the concentration of 10%, in the absence of local irritation. - Executive summary:
In a dermal sensitization study using the murine Local Lymph Node Assay (LLNA) according to OECD guideline 429 and GLP, scored as validity 1 according to Klimisch criteria, the test item was tested in two independent experiments on female CBA/J mice. First experiment, on twenty females allocated to five groups; second experiment, on twenty-eight females allocated to seven groups:
- three or five treated groups of four animals receiving the test item at different concentrations,
- one negative control group of four animals receiving the vehicle (Propylene Glycol = PG),
- one positive control group of four animals receiving the positive control, α-hexylcinnamaldehyde (HCA), a moderate sensitizer, at the concentration of 25% in Propylene Glycol.
In the first experiment, the test item was tested at the concentrations of 0.1, 1 and 10% and then in the second experiment at the concentrations of 0.256, 0.64, 1.6, 4 and 10%.
In each experiment, the test item, vehicle or positive control was applied over the ears (25 μL per ear) for three consecutive days (days 1, 2 and 3). After 2 days of resting, the proliferation of the lymph node cells in the lymph node draining the application site was measured by incorporation of tritiated methyl thymidine (day 6). The obtained values were used to calculate Stimulation Indices (SI).
The irritant potential of the test item was assessed in parallel by measurement of ear thickness on days 1, 2, 3 and 6.
First experiment:
No mortality and no clinical signs were observed during the study.
No cutaneous reactions and no noteworthy increase in ear thickness were observed in the animals of the treated groups.
A significant lymphoproliferation was noted at the concentration of 10%. In the absence of local irritation at this concentration, this effect was attributed to contact sensitization.
The EC3 value for the test item is equal to 1.9%. However, this experiment did not allow to conclude about the potential of the test item to induce contact sensitization because any dose-effect response was observed.
Second experiment:
No mortality related to treatment with the test item and no clinical signs were observed during the study.
No cutaneous reactions and no increase in ear thickness were observed in the animals of the treated groups.
A significant lymphoproliferation was noted at the concentration of 10%. In the absence of local irritation at this concentration, this effect was attributed to contact sensitization.
A dose-effect response was observed. The EC3 value for the test item is equal to 7.7%.
As all the acceptance criteria were met, this experiment was considered valid.
Under the experimental conditions of this study, the test item induced contact sensitization in the murine Local Lymph Node Assay.
According to the EC3 value obtained in the second experiment, the test item should be considered as a moderate sensitizer and classified as a skin sensitizer according to CLP criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.